Publications

Featured Publications

2024

AI-RANO

J.E.Villanueva-Meyer, S.Bakas, P.Tiwari, J.M.Lupo, E.Calabrese, C.Davatzikos, et Int, N.Galldiks, for the Response Assessment in Neuro Oncology (RANO) group. "Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements" The Lancet Oncology, 25(11):e581-e588, 2024.
S.Bakas, P.Vollmuth, N.Galldiks, T.C. Booth, H.J.W.L. Aerts, W.L.Bi, et Int, R.Y. Huang, for the Response Assessment in Neuro Oncology (RANO) group. "Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice." The Lancet Oncology, 25(11):e589-e601, 2024.

LIBI-RANO

L.Nayak, C.Bettegowda, F.Scherer, N.Galldiks, M.Ahluwalia, A.Baraniskin, et Int, R.Soffietti, "Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review". NeuroOncology. 26(6):993-1011, 2024.

PET-RANO

Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, et Int, Galldiks N. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging. 2024; 51: 3662-3679.
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, et Int, Preusser M. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. The Lancet Oncology. 2024; 25: e29-e41

RANO Resect

Karschnia P, Gerritsen JKW, Teske N, Cahill DP, Jakola AS, van den Bent M, et Int, Tonn JC (2024) The oncological role of resection in newly diagnosed glioma defined by the WHO 2021 classification: a review of the RANO resect group. The Lancet Oncology, 25: e404-e419.
Karschnia P, Dietrich J, Bruno F, Dono A, Juenger ST, Teske N, et Int, Tonn JC (2024) Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement ('low grade appearance') - a report of the RANO resect group. NeuroOncology, 26: 166-177

RAPNO

A.M.Familiar, A.F.Kazerooni, A.Vossough, J.B.Ware, S.Bagheri, N.Khalili, et Int, A.Nabavizadeh, "Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation", NeuroOncology, 26(9):1557-1571, 2024.

RANO-Cares

F.W.Boele, C.Hertler, P.Sherwood, D.Cachia, L.Dirven, J.S.Young, et Int, RANO-Cares Working Group. "Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group". Neuro-Oncology Practice, npae086, 2024.

2023

RANO Resect

Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, et Int, Tonn JC (2023) Prognostic validation and refinement of a classification system for extent of resection in glioblastoma: A report of the RANO resect group. NeuroOncology, 25: 940-954.
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, et Int, Tonn JC (2023) A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. The Lancet Oncology, 24: E438-E450.
Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, et Int, Tonn JC (2023) Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: a report of the RANO resect group. NeuroOncology, 25: 1672-1685

RANO-RT

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities, The Lancet Oncology. 2023 Aug;24(8):e344-e354. doi: 10.1016/S1470-2045(23)00297-8.

2022

AI-RANO

S.Pati, U.Baid, B.Edwards, M.Sheller, S.Wang, G.A.Reina, et Int, S.Bakas, “Federated Learning Enables Big Data for Rare Cancer Boundary Detection”, Nature Communications, 13(1):1-17, 2022.

LIBI-RANO

R.Soffietti, C.Bettegowda, I.K.Mellinghoff, K.E.Warren, M.S.Ahluwalia, J.F.De Groot, et Int, P.Y.Wen. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. NeuroOncology. 24(6):855-871, 2022.

RAPNO

H.B.Lindsay, M.Massimino, S.Avula, S.Stivaros, R.Grundy, K.Metrock, et Int, D.M.Mirsky, "Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group", The Lancet Oncology, 23(8):e393-e401, 2022.

2021

PET RANO

Galldiks N, Niyazi M, Grosu AL, Kocher M, Langen KJ, Law I, Minniti G, Kim MM, Tsien C, Dhermain F, Soffietti R, Mehta MP, Weller M, Tonn JC. Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. NeuroOncology. 2021; 23: 881-893.

2020

RANO GRP

A.S.Haider, M.v.d.Bent, P.Y.Wen, M.A.Vogelbaum, S.Chang, P.D.Canoll, C.M.Horbinski, J.T.Huse, "Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort", NeuroOncology, 22(4):450-456, 2020.

RAPNO

T.M.Cooney, K.J.Cohen, C.V.Guimaraes, G.Dhall, J.Leach, M.Massimino, et Int, K.E.Warren, "Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group", The Lancet Oncology, 21(6):e330-e336, 2020.
J.Fangusaro, O.Witt, P.H.Driever, A.K.Bag, P.d.Blank, N.Kadom, et Int, K.E.Warren, "Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group", The Lancet Oncology, 21(6):e305-e316, 2020.

2019

LIBI-RANO

Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junck L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Rudà R, Weller M, Van den Bent MJ, Vogelbaum MA, Chang S, Wen PY, Soffietti R. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. NeuroOncology. 2019 May 6;21(5):571-584.

PET RANO

Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC. PET imaging in patients with brain metastasis - report of the RANO/PET group. NeuroOncology. 2019; 21: 585-595.

2018

RAPNO

K.E.Warren, G.Vezina, T.Y.Poussaint, M.Warmuth-Metz, M.C.Chamberlain, R.J.Packer, et Int, M.W.Kieran, "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee", NeuroOncology, 20(1):13-23, 2018.

2017

RANO-TREAT

Avila EK, Chamberlain M, Schiff D, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials [published correction appears in Neuro Oncol. 2017 Feb 1;19(2):304. doi: 10.1093/neuonc/nox015]. NeuroOncology. 2017;19(1):12-21. doi:10.1093/neuonc/now190

2016

PET RANO

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. NeuroOncology. 2016; 18: 1199-1208.

2015

SPINO

I.Thibault, E.L.Chang, J.Sheehan, M.S.Ahluwalia, M.Guckenberger, M.-J.Sohn, et Int, A.Sahgal. "Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group", The Lancet Oncology, 16(16):e595-603, 2015.

Response Assessment in Neuro-Oncology (RANO) cooperative group

Featured Publications

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

This website uses cookies.